Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease (Q44363046)
Jump to navigation
Jump to search
scientific article published on 26 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease |
scientific article published on 26 June 2013 |
Statements
1 reference
Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease (English)
1 reference
Tangui Maurice
1 reference
Muhammad-Hariri Mustafa
1 reference
Catherine Desrumaux
1 reference
Emeline Keller
1 reference
Gaëlle Naert
1 reference
María de la C García-Barceló
1 reference
Yamila Rodríguez Cruz
1 reference
Julío César Garcia Rodríguez
1 reference
26 June 2013
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference